Abstract
Osteosarcoma is a rare malignant bone tumor most commonly occurring in children and young adults presenting with painful swelling. Various etiological factors for osteosarcoma are ionizing radiation, family history of bone disorders and cancer, chemicals (fluoride, beryllium, and vinyl chloride), and viruses. Status of fluoride levels in serum of osteosarcoma is still not clear. Recent reports have indicated that there is a link between fluoride exposure and osteosarcoma. Glycoproteins and glycosaminoglycans are an integral part of bone and prolonged exposure to fluoride for long duration has been shown to cause degradation of collagen and ground substance in bones. The present study was planned to analyze serum fluoride, sialic acid, calcium, phosphorus, and alkaline phosphatase levels in 25 patients of osteosarcoma and age- and sex-matched subjects with bone-forming tumours other than osteosarcoma and musculo-skeletal pain (controls, 25 each). Fluoride levels were analyzed by ISE and sialic acid was analyzed by Warren’s method. Mean serum fluoride concentration was found to be significantly higher in patients with osteosarcoma as compared to the other two groups. The mean value of flouride in patients with other bone-forming tumors was approximately 50% of the group of osteosarcoma; however, it was significantly higher when compared with patients of group I. Serum sialic acid concentration was found to be significantly raised in patients with osteosarcoma as well as in the group with other bone-forming tumors as compared to the group of controls. There was, however, no significant difference in the group of patients of osteosarcoma when compared with group of patients with other bone-forming tumors. These results showing higher level of fluoride with osteosarcoma compared to others suggesting a role of fluoride in the disease.
Similar content being viewed by others
References
Fraumeni JF Jr. Bone cancer: epidemiologic and etiologic considerations. Front Radiat Ther Oncol 1975;10: 17–27.
Operskalski EA, Martin SP , Henderson B, Vischer BR. A case control study of osteosarcoma. Am J Epidemiol 1987; 126: 118–9.
Hiramo S, Ando M. Fluoride mediates apoptosis in osteosarcoma UMR106 and its toxicity depends on the pH. Arch Toxicol 1997;72: 52–8.
Bassin EB, Wypij D, Davis RB, Mittleman MA. Age-specific fluoride exposure in drinking water and osteosarcoma. Cancer Causes Control 2006; 17:421–8.
Shusheela AK, Jha M. Fluoride ingestion and its influence on glucosaminoglycans in cancellous and cortical bones—a structural and biochemical study. Fluoride 1982; 15: 191–8.
Venkateswarlu P. Evaluation of analytical method for fluorine in biological and related materials. J Dent Res 1990; 69: 514–21.
Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971–5.
Bretandiere JP, Vassault A, Amsellem L, Pourci ML, Phung HT, Bailly M. Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin Chem 1977;23:2263–74.
Bauer PJ. Affinity and stoichiometry of calcium binding by arsenazo III. Anal Biochem 1981; 110: 61–72.
Daly JA, Ertinghausen G. Direct method for determining inorganic phosphate in serum with the “centrifi chem.”. Clin Chem 1972;18:263–65.
Jolly SS, Singh ID, Prasad S, Sharma R, Singh BM, Mathur OC. An epidemiological study of endemic fluorosis in Punjab. Ind J Med Res 1969;57:1333.
Jha M, Shusheela AK, Neelam K, Rajyalaxmi K, Venkiah K. Excessive ingestion of fluoride and the significance of sialic acid: glycosaminoglycans in serum of rabbit and human subjects. Clin Toxicol 1983; 19: 1023–30.
Yiamouyiannis JA Fluoridation and cancer. The biology and epidemiology of bone and oral cancer related to fluoridation. Fluoride 1993; 26: 83–96.
Gelberg KH, Fitzgerald EF, Synian H, Robert D. Fluoride exposure and childhood osteosarcoma: A Case Control Study. Am J Public Health 1995; 85:1678–83.
Schlesinger ER, Overton DE, Chase HC, Cantwell KJ. Newburgh Kingston caries–fluorine study XIII, pediatric findings after ten years. JADA 1956;52:296–306.
Pasquini GMF, Davey RAM, Michelangeli VP, Grill V, Kaczmarczyk SJ, Zajac JD. Local secretion of parathyroid hormone related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition. Bone 2002;31:598–605.
Bacci G, Ferrari S, Longhi A. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 2001; 37: 32–8.
Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Cancer 2006; 106: 1154–61.
Gelberg KH, Fitzgerald EF, Synian H, Robert D. Fluoride exposure and childhood osteosarcoma: A Case Control Study. Am J Public Health 1995; 85:1678–83.
Dwivedi C, Dixit M, Kumar SS, Reddy H, Semenya KA, Hardy RE. Plasma sialic acid alterations in neoplastic diseases. J Med 1987;18:323–32.
Jha M, Shusheela AK, Neelam K, Rajyalaxmi K, Venkiah K. Excessive ingestion of fluoride and the significance of sialic acid: glycosaminoglycans in serum of rabbit and human subjects. Clin Toxicol 1983; 19: 1023–30.
Mcneil C, Berrett CR, Su LY, Trentelman EF, Helmick WM. Sialic acid as a measure of serum mucoproteins. Am J Clin Pathol 1965;43:130–3.
Singh R, Ramraju B. Serum sialic acid values in healthy Indian adults. Ind J Med Res 1967;55:267–9.
Schauer R, Corfield AP. Colorimetry and thin-layer chromatography of sialic acids. In: Schaur R, editor. Sialic acids, chemistry, metabolism and function. Vienna: Springer, 1982. p.77–94.
Gupta AK, Sur BK, Taneja DK. Serum sialic acid in different bone disorders. J Ind Med Assoc 1973; 60: 87–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sandhu, R., Lal, H., Kundu, Z.S. et al. Serum Fluoride and Sialic Acid Levels in Osteosarcoma. Biol Trace Elem Res 144, 1–5 (2011). https://doi.org/10.1007/s12011-009-8382-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-009-8382-1